Skip to main content

Polymorphism of Apolipoproteine E in Relation with Alzheimer and Vascular Dementia

Cellular and Molecular Neurobiology volume 26, pages 1217–1222 (2006)Cite this article

Summary

1. The epsilon 4 allele of the apolipoprotein E gene increases the risk of late onset familial and sporadic Alzheimer disease. Relation of epsilon 4 allele of the apolipoprotein E gene to various types of dementia and the onset of dementia were analyzed in the present study.

2. The study comprised 139 patients (50 men and 89 women) with dementia, mean age 73.61 years (range 47–98). The diagnosis of dementia was made according to Diagnostic and Statistical Manual of Mental Disorders, and subtypes diagnoses were made according to NINCDS-ADRDA and NINDS-AIREN criteria. Minimental State Examination (MMSE) was used for the screening of dementia. Apolipoprotein E polymorphism was determined by the PCR-RFLP technique-polymerase chain reaction and subsequent digestion with specific restriction endonuclease. For statistical analyses chi-square test and the crude Gart´s odds ratio (OR) and 95% confidence intervals (CI) were used.

3. From 139 dementia patients (MMSE ≤24 points) in 61 (45%) Alzheimer disease (AD) was present, in 44 patients (31%) vascular dementia (VD), and in 34 (24%) mixed dementia (MD) were revealed. In comparison with control group the presence of at least one ApoE-ɛ4 allele was significantly higher only in the group with AD (p < 0.001), (OR=2.76; 95%: 1.42–5.36). The frequency of ɛ4 allele carriers was significantly overrepresented in AD group compared with VD (χ2=5.94; p=0.0148). Differences between AD and MD or VD and MD were not confirmed.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1.

REFERENCES

  • Bales, K. R., Verina, T., and Dodel, R. C. (1997). Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17:263–264.

    Article  CAS  PubMed  Google Scholar 

  • Brecht, W. J., Hartus, F. M., Chány, S., Tesseur, I., Yu, G. Q., Xu, Q., Dee Fish, J., Wyss-Coray, T., Buttini, M., Mucke, L., Mahely, R. W., and Juany, Y. (2004). Neurospecific apolipoprotein (4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J. Neurosci. 24:2527–2534.

    Article  CAS  PubMed  Google Scholar 

  • Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. V., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer´s disease in late onset families. Science 261:921–923.

    Article  CAS  PubMed  Google Scholar 

  • Chapman, J., Estupinam, J., Asherov, A., and Goldfarb, L. G. (1996). A simple and efficient method for apolipoprotein E genotype determination. Neurology 46:1484–1485.

    CAS  PubMed  Google Scholar 

  • Davignon, J., Gregg, R. E., and Sing, C. F. (1988). Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1–21.

    CAS  PubMed  Google Scholar 

  • Ewbank, D. C. (2002). Mortality differences by APOE genotype estimated from demographic synthesis. Genet. Epidemiol. 22:146–155.

    Article  PubMed  Google Scholar 

  • Fratiglioni, M. D., Launer, L. J., Andersen, K., Breteler, M. M. B., Copeland, J. R. M., Dartigues, J. -F., Lobo, A., Martinez-Lage, J., Soininen, H., and Hofman, A. (2000). Incidenece of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology 54(Suppl): S10–S15.

    CAS  PubMed  Google Scholar 

  • Handelmann, G. E., Boyles, J. K., Weisgraber, K. H., Mahley, R. W., and Pitas, R. E. (1992). Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J. Lipid Res. 33:1677–1688.

    CAS  PubMed  Google Scholar 

  • Lehtimäki, T., Pirttilä, T., Mehta, P. D., Wisniewski, H. M., Frey, H., and Nikkari, T. (1995). Apolipoprotein E (ApoE) polymorphism and its influence on ApoE concentration in the cerobrospinal fluid in Finnish patients with Alzheimer´s disease. Hum. Genet. 95:39–42.

    Article  PubMed  Google Scholar 

  • Mechirova, E., and Domorakova, I. (2004). NADPH-diaphorase activity in the spinal cord after ischemic injury and the effects of pretreatment with Ginkgo biloba extract (EGb 761). Acta Histochemica 104:427–430.

    Article  Google Scholar 

  • Prince, M., Lovestone, S., Cervilla, J., Joels, S., Powell, J., Russ, C., and Mann, A. (2000). The association between ApoE and deemtnia does not seem to be mediated by vascular factors. Neurology 54:397–402.

    CAS  PubMed  Google Scholar 

  • Saunders, A. M., Hulette, C., and Welsh-Bohmer, K. A. (1996). Specificity, sensitivity, and predictive value apolipoprotein-E genotyping for sporadic Alzheimer´s disease. Lancet 348:90–93.

    Article  CAS  PubMed  Google Scholar 

  • Sparks, D. L. (1997). Coronary artery disease, hypertension, ApoE, and cholesterol: A link to Alzheimer´s disease?. Ann. N.Y. Acad. Sci. (1997). 826:128–146.

    CAS  Google Scholar 

  • Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., and Roses, A. D. (1993). Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer´s disease. Proc. Natl. Acad. Sci. U.S.A. 90:1977–1981.

    Article  CAS  PubMed  Google Scholar 

  • Strittmatter, W. J., Weisgraber, K. H., Goedert, M., Saunders, A. M., Huang, D., Corder, E. H., Dong, L. M., Jakes, R., Alberts, M. J., Gilbert, J. R., Han, S. H, Hulette, C., Einstein, G., Schmechel, D. E., Pericak-Vance, M. A., and Roses, A. D. (1994). Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein genotype. Exp. Neurol. 125:163–171.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The study was supported by Grant VEGA 1/2319/05.

Author information

Affiliations

  1. Department of Neurology, Faculty of Medicine, P.J. Šafarik University and Faculty Hospital Louis Pasteur, Tr. SNP 1, 04011, Košice, Slovak Republic

    Zuzana Gdovinová & Zuzana Novosadová

  2. Department of Medical Biology, Faculty of Medicine, P.J. Šafarik University, Košice, Slovak Republic

    Viera Habalová

  3. Department of Neurology, Faculty of Medicine, P.J. Šafarik University and Faculty Hospital Louis Pasteur, Tr. SNP 1, 04011, Košice, Slovak Republic

    Zuzana Gdovinová

Authors
  1. Zuzana Gdovinová
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Viera Habalová
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zuzana Novosadová
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zuzana Gdovinová.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gdovinová, Z., Habalová, V. & Novosadová, Z. Polymorphism of Apolipoproteine E in Relation with Alzheimer and Vascular Dementia. Cell Mol Neurobiol 26, 1217–1222 (2006). https://doi.org/10.1007/s10571-006-9043-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-006-9043-y

KEY WORDS:

  • Alzheimer disease
  • vascular dementia
  • apolipoprotein E